Loading...

Oudiz Ronald J.

Title(s)Professor, Cardiology
SchoolThe Lundquist Institute for Biomedical Innovation
Phone(310) 787-0448
vCardDownload vCard
    Other Positions
    Title(s)Professor, Medicine


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Russell S, Beghetti M, Oudiz R, Balagtas C, Zhang M, Ivy D. Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial. Open Heart. 2019; 6(2):e001149. PMID: 31908813.
      View in: PubMed
    2. McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rubin LJ, Blair C, Langley J, Hoeper MM. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. J Heart Lung Transplant. 2019 Dec; 38(12):1286-1295. PMID: 31648845.
      View in: PubMed
    3. White RJ, Vonk-Noordegraaf A, Rosenkranz S, Oudiz RJ, McLaughlin VV, Hoeper MM, Grünig E, Ghofrani HA, Chakinala MM, Barberà JA, Blair C, Langley J, Frost AE. Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension. Respir Res. 2019 Sep 12; 20(1):208. PMID: 31511080.
      View in: PubMed
    4. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, Oudiz R, Satoh T, Torres F, Torbicki A. Diagnosis of pulmonary hypertension. Eur Respir J. 2019 Jan; 53(1). PMID: 30545972.
      View in: PubMed
    5. Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019 Mar; 7(3):227-238. PMID: 30527956.
      View in: PubMed
    6. Young A, Nagaraja V, Basilious M, Habib M, Townsend W, Gladue H, Badesch D, Gibbs JSR, Gopalan D, Manes A, Oudiz R, Satoh T, Torbicki A, Torres F, McLaughlin V, Khanna D. Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. Semin Arthritis Rheum. 2019 06; 48(6):1059-1067. PMID: 30415942.
      View in: PubMed
    7. Agarwal MA, Shah M, Patel B, Nolan VG, Reed GL, Oudiz RJ, Choudhary G, Maron BA. Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease. Am J Respir Crit Care Med. 2018 08 15; 198(4):534-537. PMID: 29648884.
      View in: PubMed
    8. Shapiro S, Torres F, Feldman J, Keogh A, Allard M, Blair C, Gillies H, Tislow J, Oudiz RJ. Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1). Respir Med. 2017 05; 126:84-92. PMID: 28427554.
      View in: PubMed
    9. Oudiz R, Agarwal M, Rischard F, De Marco T. An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension. Pulm Circ. 2016 Dec; 6(4):532-538. PMID: 28090295.
      View in: PubMed
    10. Hoeper MM, McLaughlin VV, Barberá JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rosenkranz S, Oudiz RJ, White RJ, Miller KL, Langley J, Harris JHN, Blair C, Rubin LJ, Vachiery JL. Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study. Lancet Respir Med. 2016 11; 4(11):894-901. PMID: 27745818.
      View in: PubMed
    11. Oudiz RJ. Classification of Pulmonary Hypertension. Cardiol Clin. 2016 Aug; 34(3):359-61. PMID: 27443133.
      View in: PubMed
    12. Oudiz RJ. Pulmonary Hypertension. Cardiol Clin. 2016 Aug; 34(3):ix. PMID: 27443144.
      View in: PubMed
    13. Gomberg-Maitland M, Schilz R, Mediratta A, Addetia K, Coslet S, Thomeas V, Gillies H, Oudiz RJ. Phase I safety study of ranolazine in pulmonary arterial hypertension. Pulm Circ. 2015 Dec; 5(4):691-700. PMID: 26697176.
      View in: PubMed
    14. Kholdani CA, Oudiz RJ, Fares WH. The Assessment of the Right Heart Failure Syndrome. Semin Respir Crit Care Med. 2015 Dec; 36(6):934-42. PMID: 26595052.
      View in: PubMed
    15. Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015 Aug 27; 373(9):834-44. PMID: 26308684.
      View in: PubMed
    16. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM. [Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:29-44. PMID: 25697032.
      View in: PubMed
    17. Frantz RP, Durst L, Burger CD, Oudiz RJ, Bourge RC, Franco V, Waxman AB, McDevitt S, Walker S. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):550-7. PMID: 24742768.
      View in: PubMed
    18. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D22-33. PMID: 24355638.
      View in: PubMed
    19. Lewis GD, Bossone E, Naeije R, Grünig E, Saggar R, Lancellotti P, Ghio S, Varga J, Rajagopalan S, Oudiz R, Rubenfire M. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation. 2013 Sep 24; 128(13):1470-9. PMID: 24060943.
      View in: PubMed
    20. Hassoun PM, Nikkho S, Oudiz RJ. Updating clinical endpoints in pulmonary arterial hypertension: when challenges are welcome. Pulm Circ. 2013 Sep; 3(3):721-2. PMID: 24618557.
      View in: PubMed
    21. Oudiz RJ. Death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013 Aug 01; 188(3):269-70. PMID: 23905521.
      View in: PubMed
    22. Bonderman D, Ghio S, Felix SB, Ghofrani HA, Michelakis E, Mitrovic V, Oudiz RJ, Boateng F, Scalise AV, Roessig L, Semigran MJ. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation. 2013 Jul 30; 128(5):502-11. PMID: 23775260.
      View in: PubMed
    23. Fritz JS, Blair C, Oudiz RJ, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM. Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension. Chest. 2013 Feb 01; 143(2):315-323. PMID: 22814814.
      View in: PubMed
    24. McLaughlin VV, Langer A, Tan M, Clements PJ, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest. 2013 Feb 01; 143(2):324-332. PMID: 22910999.
      View in: PubMed
    25. Hassoun PM, Nikkho S, Rosenzweig EB, Moreschi G, Lawrence J, Teeter J, Meier C, Ghofrani AH, Minai O, Rinaldi P, Michelakis E, Oudiz RJ. Updating clinical endpoint definitions. Pulm Circ. 2013 Jan; 3(1):206-16. PMID: 23662199.
      View in: PubMed
    26. Howard L, Grocott MP, Naeije R, Oudiz R, Wensel R. Cardiopulmonary exercise testing. Pulm Med. 2012; 2012:564134. PMID: 23365737.
      View in: PubMed
    27. Oudiz RJ, Brundage BH, Galiè N, Ghofrani HA, Simonneau G, Botros FT, Chan M, Beardsworth A, Barst RJ. Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study. J Am Coll Cardiol. 2012 Aug 21; 60(8):768-74. PMID: 22818063.
      View in: PubMed
    28. Ghio S, Bonderman D, Felix SB, Ghofrani HA, Michelakis ED, Mitrovic V, Oudiz RJ, Frey R, Roessig L, Semigran MJ. Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design. Eur J Heart Fail. 2012 Aug; 14(8):946-53. PMID: 22719060.
      View in: PubMed
    29. Clements PJ, Tan M, McLaughlin VV, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012 Feb; 71(2):249-52. PMID: 21998119.
      View in: PubMed
    30. Badesch DB, Feldman J, Keogh A, Mathier MA, Oudiz RJ, Shapiro S, Farber HW, McGoon M, Frost A, Allard M, Despain D, Dufton C, Rubin LJ. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. Cardiovasc Ther. 2012 Apr; 30(2):93-9. PMID: 21884013.
      View in: PubMed
    31. Khanna D, Kowal-Bielecka O, Khanna PP, Lapinska A, Asch SM, Wenger N, Brown KK, Clements PJ, Getzug T, Mayes MD, Medsger TA, Oudiz R, Simms R, Steen V, Maranian P, Furst DE. Quality indicator set for systemic sclerosis. Clin Exp Rheumatol. 2011 Mar-Apr; 29(2 Suppl 65):S33-9. PMID: 21586216.
      View in: PubMed
    32. Klinger JR, Oudiz RJ, Spence R, Despain D, Dufton C. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension. Am J Cardiol. 2011 Jul 15; 108(2):302-7. PMID: 21545989.
      View in: PubMed
    33. Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. J Am Coll Cardiol. 2011 Mar 01; 57(9):1053-61. PMID: 21349396.
      View in: PubMed
    34. Barst RJ, Oudiz RJ, Beardsworth A, Brundage BH, Simonneau G, Ghofrani HA, Sundin DP, Galiè N. Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2011 Jun; 30(6):632-43. PMID: 21256048.
      View in: PubMed
    35. Dumitrescu D, Oudiz RJ, Karpouzas G, Hovanesyan A, Jayasinghe A, Hansen JE, Rosenkranz S, Wasserman K. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One. 2010 Dec 13; 5(12):e14293. PMID: 21179195.
      View in: PubMed
    36. Oudiz RJ, Midde R, Hovenesyan A, Sun XG, Roveran G, Hansen JE, Wasserman K. Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2010 Apr 15; 105(8):1186-91. PMID: 20381675.
      View in: PubMed
    37. Shoemaker MJ, Wilt JL, Dasgupta R, Oudiz RJ. Exercise training in patients with pulmonary arterial hypertension: a case report. Cardiopulm Phys Ther J. 2009 Dec; 20(4):12-8. PMID: 20467524.
      View in: PubMed
    38. Oudiz RJ, Galiè N, Olschewski H, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Harrison BC, Despain D, Dufton C, Rubin LJ. Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Nov 17; 54(21):1971-81. PMID: 19909879.
      View in: PubMed
    39. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S55-66. PMID: 19555859.
      View in: PubMed
    40. McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galiè N, Gibbs JS, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W. End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S97-107. PMID: 19555863.
      View in: PubMed
    41. Aboulhosn JA, Oudiz RJ, Dave AS, Ardehali A, Ross DJ. Successful tricuspid valve replacement in a patient with severe pulmonary arterial hypertension and preserved right ventricular systolic function. Case Rep Med. 2009; 2009:108295. PMID: 19707472.
      View in: PubMed
    42. Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009 Jun 09; 119(22):2894-903. PMID: 19470885.
      View in: PubMed
    43. Oudiz RJ, Farber HW. Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review. Am Heart J. 2009 Apr; 157(4):625-35. PMID: 19332188.
      View in: PubMed
    44. Oudiz RJ, Rubin LJ. Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. Circulation. 2008 Nov 18; 118(21):2120-1. PMID: 19015412.
      View in: PubMed
    45. McGoon MD, Frost AE, Oudiz RJ, Badesch DB, Galie N, Olschewski H, McLaughlin VV, Gerber MJ, Dufton C, Despain DJ, Rubin LJ. Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities. Chest. 2009 Jan; 135(1):122-129. PMID: 18812445.
      View in: PubMed
    46. Galiè N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Gerber MJ, Dufton C, Wiens BL, Rubin LJ. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008 Jun 10; 117(23):3010-9. PMID: 18506008.
      View in: PubMed
    47. McSwain CS, Benza R, Shapiro S, Hill N, Schilz R, Elliott CG, Zwicke DL, Oudiz RJ, Staszewski JP, Arneson CP, Wade M, Zaccardelli D, McLaughlin V. Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. J Clin Pharmacol. 2008 Jan; 48(1):19-25. PMID: 18094217.
      View in: PubMed
    48. Nahapetian A, Oudiz RJ. Serial hemodynamics and complications of pregnancy in severe pulmonary arterial hypertension. Cardiology. 2008; 109(4):237-40. PMID: 17873487.
      View in: PubMed
    49. Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail. 2007 Sep; 9(9):917-21. PMID: 17707133.
      View in: PubMed
    50. Budoff MJ, Gopal A, Gul KM, Mao SS, Fischer H, Oudiz RJ. Prevalence of obstructive coronary artery disease in an outpatient cardiac CT angiography environment. Int J Cardiol. 2008 Sep 16; 129(1):32-6. PMID: 17651836.
      View in: PubMed
    51. Girgis RE, Frost AE, Hill NS, Horn EM, Langleben D, McLaughlin VV, Oudiz RJ, Robbins IM, Seibold JR, Shapiro S, Tapson VF, Barst RJ. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis. 2007 Nov; 66(11):1467-72. PMID: 17472992.
      View in: PubMed
    52. Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med. 2007 Mar; 28(1):233-41, x. PMID: 17338938.
      View in: PubMed
    53. Benza RL, Mehta S, Keogh A, Lawrence EC, Oudiz RJ, Barst RJ. Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan. J Heart Lung Transplant. 2007 Jan; 26(1):63-9. PMID: 17234519.
      View in: PubMed
    54. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006 Dec 19; 48(12):2546-52. PMID: 17174196.
      View in: PubMed
    55. Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL, Gonin R, Keast S, Badesch D, Barst RJ, Bourge RC, Channick R, Frost A, Gaine S, McGoon M, McLaughlin V, Murali S, Oudiz RJ, Robbins IM, Tapson V, Abenhaim L, Constantine G. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J. 2006 Sep; 152(3):521-6. PMID: 16923424.
      View in: PubMed
    56. McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006 Dec 01; 174(11):1257-63. PMID: 16946127.
      View in: PubMed
    57. Gul KM, Mao SS, Gao Y, Oudiz RJ, Rasouli ML, Gopal A, Budoff MJ. Noninvasive gadolinium-enhanced three dimensional computed tomography coronary angiography. Acad Radiol. 2006 Jul; 13(7):840-9. PMID: 16777558.
      View in: PubMed
    58. Oudiz RJ, Barst RJ, Hansen JE, Sun XG, Garofano R, Wu X, Wasserman K. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol. 2006 Jan 01; 97(1):123-6. PMID: 16377296.
      View in: PubMed
    59. Galié N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, Frost AE, Zwicke D, Naeije R, Shapiro S, Olschewski H, Rubin LJ. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2005 Aug 02; 46(3):529-35. PMID: 16053970.
      View in: PubMed
    60. Oudiz RJ. The role of exercise testing in the management of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2005 Aug; 26(4):379-84. PMID: 16121314.
      View in: PubMed
    61. Mao S, Shinbane JS, Girsky MJ, Child J, Carson S, Oudiz RJ, Budoff MJ. Coronary venous imaging with electron beam computed tomographic angiography: three-dimensional mapping and relationship with coronary arteries. Am Heart J. 2005 Aug; 150(2):315-22. PMID: 16086937.
      View in: PubMed
    62. Mao S, Shinbane JS, Oudiz RJ, Flores F, Chau A, Liu S, Wang S, Gao Y, Budoff MJ. Detection of small vessels with electron beam computed tomographic angiography using 1.5 and 3 mm collimator protocols. Int J Cardiovasc Imaging. 2006 Apr; 22(2):275-82. PMID: 16041563.
      View in: PubMed
    63. Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005 May; 127(5):1637-46. PMID: 15888840.
      View in: PubMed
    64. Budoff MJ, Shinbane JS, Oudiz RJ, Child J, Carson S, Chau A, Tseng P, Gao Y, Mao S. Comparison of coronary artery calcium screening image quality between C-150 and e-Speed electron beam scanners. Acad Radiol. 2005 Mar; 12(3):309-12. PMID: 15766691.
      View in: PubMed
    65. Oudiz RJ, Wasserman K. Clinical efficacy of sildenafil in primary pulmonary hypertension. J Am Coll Cardiol. 2004 Dec 07; 44(11):2256; author reply 2256-7. PMID: 15582332.
      View in: PubMed
    66. Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest. 2004 Aug; 126(2):420-7. PMID: 15302727.
      View in: PubMed
    67. Oudiz RJ, Widlitz A, Beckmann XJ, Camanga D, Alfie J, Brundage BH, Barst RJ. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest. 2004 Jul; 126(1):90-4. PMID: 15249447.
      View in: PubMed
    68. Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AE, Torbicki A. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):48S-55S. PMID: 15194178.
      View in: PubMed
    69. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, McLaughlin V, Hill N, Tapson VF, Robbins IM, Zwicke D, Duncan B, Dixon RA, Frumkin LR. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004 Feb 15; 169(4):441-7. PMID: 14630619.
      View in: PubMed
    70. Mao S, Takasu J, Child J, Carson S, Oudiz R, Budoff MJ. Comparison of LV mass and volume measurements derived from electron beam tomography using cine imaging and angiographic imaging. Int J Cardiovasc Imaging. 2003 Oct; 19(5):439-45. PMID: 14609196.
      View in: PubMed
    71. Oudiz RJ, Ginzton L. Pulmonary artery systolic pressure estimated by echocardiogram vs catheterization in patients awaiting lung transplantation. J Heart Lung Transplant. 2003 Jul; 22(7):832-3; author reply 833. PMID: 12873560.
      View in: PubMed
    72. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Jun 18; 41(12):2119-25. PMID: 12821234.
      View in: PubMed
    73. Mao S, Lu B, Takasu J, Oudiz RJ, Budoff MJ. Measurement of the RT interval on ECG records during electron-beam CT. Acad Radiol. 2003 Jun; 10(6):638-43. PMID: 12809417.
      View in: PubMed
    74. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003 Mar 19; 41(6):1028-35. PMID: 12651053.
      View in: PubMed
    75. Mao S, Child J, Carson S, Liu SC, Oudiz RJ, Budoff MJ. Sensitivity to detect small coronary artery calcium lesions with varying slice thickness using electron beam tomography. Invest Radiol. 2003 Mar; 38(3):183-7. PMID: 12595800.
      View in: PubMed
    76. McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol. 2003 Feb; 41(2):293-9. PMID: 12548091.
      View in: PubMed
    77. Yamamoto H, Budoff MJ, Lu B, Takasu J, Oudiz RJ, Mao S. Reproducibility of three different scoring systems for measurement of coronary calcium. Int J Cardiovasc Imaging. 2002 Oct; 18(5):391-7. PMID: 12194680.
      View in: PubMed
    78. Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Solèr M. Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J. 2002 May; 143(5):E4. PMID: 12040360.
      View in: PubMed
    79. Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002 Mar 15; 165(6):800-4. PMID: 11897647.
      View in: PubMed
    80. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation. 2002 Jan 01; 105(1):54-60. PMID: 11772876.
      View in: PubMed
    81. Oudiz RJ. Secondary Pulmonary Hypertension. Curr Treat Options Cardiovasc Med. 2001 Apr; 3(2):115-124. PMID: 11242558.
      View in: PubMed